cysteamine has been researched along with Breast Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bebawy, M; Luk, F; Roseblade, A; Ung, A | 1 |
| Coulombel, L; Dordick, JS; Kim, JH; Kim, MI; Ku, B; Kwon, SJ; Linhardt, RJ; Shawky, JH | 1 |
| Bekis, R; Kozgus, O; Medine, EI; Ozkaya, F; Sakarya, S; Timur, S; Unak, G; Unak, P | 1 |
| Audette, M; Charest-Gaudreault, R; Dionne, P; Gamache, I; Huber, M; Pelletier, JG; Poulin, R; Torossian, K | 1 |
4 other study(ies) available for cysteamine and Breast Neoplasms
| Article | Year |
|---|---|
Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.
Topics: Acrylates; Amides; Antineoplastic Agents; Breast Neoplasms; Calcimycin; Cell Line, Tumor; Cell-Derived Microparticles; Cystamine; Cysteamine; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Oligopeptides; Pantetheine; Pyridines; Verapamil | 2015 |
Unnatural polyketide analogues selectively target the HER signaling pathway in human breast cancer cells.
Topics: Acyltransferases; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cysteamine; Enzymes, Immobilized; ErbB Receptors; Female; Humans; Macrolides; Medicago sativa; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrones; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction | 2010 |
Gold nanoparticle probes: design and in vitro applications in cancer cell culture.
Topics: Antibodies; Apoptosis; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cysteamine; Disulfides; Female; Fluorodeoxyglucose F18; Gold; Halogenation; Humans; Immunoconjugates; Isotope Labeling; Mannose; Membrane Proteins; Mesylates; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular Targeted Therapy; RNA-Binding Proteins | 2012 |
2,2'-Dithiobis(N-ethyl-spermine-5-carboxamide) is a high affinity, membrane-impermeant antagonist of the mammalian polyamine transport system.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Membrane; CHO Cells; Cricetinae; Cycloheximide; Cysteamine; Disulfides; Female; Humans; Indicators and Reagents; Kinetics; Molecular Structure; Polyamines; Putrescine; Spermidine; Spermine; Structure-Activity Relationship; Sulfhydryl Compounds; Tumor Cells, Cultured | 1996 |